CARDIAC RISK ASSESSMENT (D-DIMER, GLUCOSE – RANDOM, HS-CRP, LIPID PROFILE, HOMOCYSTEINE)

The Cardiac Risk Assessment is a combined blood-test panel that measures D-dimer, random glucose, high-sensitivity C-reactive protein (hs-CRP), lipid profile and homocysteine. These tests evaluate different biological factors that may be relevant to cardiovascular health, including abnormal blood lipids, blood-glucose status, low-grade inflammation, homocysteine concentration and evidence of increased blood-clot formation and breakdown.

Cardiovascular disease develops through the interaction of multiple factors such as age, blood pressure, diabetes, smoking, abnormal cholesterol, obesity, physical inactivity, family history and existing medical conditions. No single laboratory value can determine a person's complete cardiac risk. This panel gives doctors additional laboratory information that must be interpreted with symptoms, examination findings, blood pressure and medical history.

The lipid profile generally measures total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides. Random glucose measures blood sugar at the time the sample is collected. hs-CRP detects relatively low concentrations of C-reactive protein and may provide information about systemic inflammation. Homocysteine is an amino acid whose concentration may increase due to nutritional, genetic, medicine-related or medical factors. D-dimer measures a protein fragment produced when a blood clot is broken down.

Benefits of the Test

• Evaluates several cardiovascular and metabolic markers using one blood sample.
• Measures cholesterol and triglyceride levels associated with atherosclerotic cardiovascular risk.
• Provides a random glucose value that may indicate abnormal blood-sugar regulation.
• Measures hs-CRP as a marker of low-grade systemic inflammation.
• Checks homocysteine concentration, which may be elevated in certain nutritional and medical conditions.
• Includes D-dimer to support clot-related evaluation when clinically appropriate.
• Provides baseline values that doctors can compare with future results.
• Supports personalised decisions regarding further testing and risk-factor management.

Why Doctors Recommend This Test

A doctor may recommend this panel for people with multiple cardiovascular risk factors, including high blood pressure, diabetes, obesity, smoking, sedentary lifestyle, abnormal cholesterol, chronic stress or a family history of premature heart disease or stroke. It may also be considered when previous test results suggest dyslipidaemia, impaired glucose regulation or increased inflammation.

The lipid profile is an important part of cardiovascular risk assessment because elevated LDL cholesterol and triglycerides, or reduced HDL cholesterol, may be associated with a higher risk of plaque formation in the arteries. Results are assessed together with age, blood pressure, diabetes status, smoking history and other clinical information.

Random glucose can help identify a high blood-glucose level at the time of collection. However, one abnormal random value does not always diagnose diabetes. Depending on the result and symptoms, a doctor may recommend fasting glucose, HbA1c or an oral glucose tolerance test.

hs-CRP may be used selectively to refine cardiovascular risk assessment, particularly when a person's risk is otherwise uncertain. Because hs-CRP can rise during infection, injury or inflammatory illness, testing during an acute illness may not reflect usual cardiovascular risk.

Homocysteine may be elevated due to vitamin B12, folate or vitamin B6 deficiency, kidney disease, thyroid-related conditions, genetic factors and certain medicines. Although an elevated level has been associated with vascular risk, it is not a stand-alone predictor of a heart attack or stroke.

D-dimer has a different clinical role from the other markers in this panel. It is mainly used with clinical assessment to help evaluate suspected blood-clot disorders such as deep-vein thrombosis or pulmonary embolism. A raised D-dimer is nonspecific and does not independently confirm a blood clot, heart attack or cardiovascular disease.

Preparation Before Test

Ask the doctor or laboratory whether fasting is required. Random glucose itself does not require fasting, but the laboratory may advise fasting for approximately 8–12 hours to obtain a fasting lipid profile. During fasting, plain water is generally permitted unless the healthcare professional provides different instructions.

Avoid alcohol and unusually heavy or fatty meals before testing if instructed. Strenuous exercise may temporarily influence some measured markers. Follow the normal routine unless the doctor provides specific preparation instructions.

Inform the doctor about all prescribed medicines, over-the-counter medicines, vitamins and nutritional supplements. Medicines and supplements may affect glucose, lipid, inflammation or homocysteine results. Do not stop any prescribed treatment without medical advice.

Tell the healthcare professional about recent infection, fever, injury, surgery, pregnancy, prolonged immobility or a previously diagnosed blood clot. These factors are particularly important when interpreting D-dimer and hs-CRP. A blood sample will usually be collected from a vein in the arm.

Normal Reporting Time

The Cardiac Risk Assessment report is commonly available within 24 hours after the laboratory receives a suitable blood sample. Reporting may occasionally take longer because individual components can require separate processing, quality checks or clinical verification. The exact turnaround time depends on the collection time and laboratory workflow.

Who Should Take This Test?

This panel may be considered for adults with a family history of premature cardiovascular disease, abnormal cholesterol, diabetes, hypertension, obesity, smoking history or other recognised cardiac risk factors. It may also be requested when a doctor needs broader laboratory information before planning preventive care or additional investigations.

D-dimer testing should be interpreted only in the appropriate clinical setting. Anyone experiencing sudden chest pain, severe breathlessness, coughing blood, fainting or painful swelling of one leg should seek urgent medical attention instead of relying on a routine laboratory package.

The panel is not a substitute for an ECG, echocardiogram, cardiac-troponin test, stress test, vascular imaging or emergency evaluation when these are clinically required. A normal panel cannot guarantee that the heart and blood vessels are free from disease.

Detailed Information

The lipid profile evaluates fats transported in the blood. LDL cholesterol can contribute to plaque accumulation in artery walls, while HDL participates in transporting cholesterol away from tissues. Triglycerides are another type of circulating fat. Interpretation depends on the complete risk profile rather than one universal target for every person.

Random glucose reflects the blood-glucose level at the moment of collection and can be affected by meals, activity, stress, illness and medicines. Markedly abnormal results require medical review and may need confirmation using diagnostic diabetes tests.

hs-CRP measures lower CRP concentrations than a standard CRP assay. Elevated hs-CRP can be associated with cardiovascular risk, but infection, inflammatory disease, trauma and other conditions may also increase it. A doctor may recommend repeating the measurement when the person is clinically stable.

Homocysteine is formed during methionine metabolism. Vitamins B12, B6 and folate participate in its processing. An elevated result may lead to evaluation of nutritional status, kidney function, thyroid function, medicine use and other possible causes.

D-dimer is released when cross-linked fibrin is broken down. A low result may help exclude certain blood clots in appropriately selected patients with low or intermediate clinical probability. An elevated result requires clinical correlation and may lead to ultrasound, CT pulmonary angiography or other imaging. Age, pregnancy, infection, inflammation, surgery, trauma, liver disease and cancer may also raise D-dimer.

Reference intervals, units and clinical decision limits vary according to the test method and laboratory. Each component should be interpreted using the range printed on the report. Doctors should combine the results with symptoms, physical findings, blood pressure, lifestyle, family history and any additional cardiac or vascular investigations.